Decoding Immune Pathways of Leprosy Reactions Enables Precision Diagnostics and Treatment, Suggests Review Aashi verma2 Jun 2026 9:00 PM ISTA recent comprehensive review published in the Indian Journal of Dermatology, Venereology, and Leprology in June 2025 reveals that decoding the...
Phase III Trial Reports Positive Topline Results for Candin in Common Warts Dr. Kamal Kant Kohli1 Jun 2026 8:15 PM ISTTopline data from a completed phase III trial evaluating Candin (Purified Candida albicans Antigen) demonstrated its potential effectiveness in the...
Scars of life: study shows impact of atopic dermatitis on educational and career choices Dr. Kamal Kant Kohli31 May 2026 8:30 PM ISTAtopic dermatitis (AD), the most common form of eczema, impacts patients' life trajectories beyond the physical scars. A novel study shows that adults...
Electroacupuncture Reduces Pain in Postherpetic Neuralgia Patients, New Trial Finds Medha Baranwal29 May 2026 8:45 PM ISTChina: A multicenter randomized clinical trial published in JAMA Neurology has reported that electroacupuncture may offer meaningful pain relief in...
Hydroxychloroquine Linked to Lower Cardiometabolic Risk in Cutaneous Lupus, researchers find Dr. Kamal Kant Kohli28 May 2026 8:45 PM ISTA study led by investigators from Johns Hopkins Medicine found that some patients with discoid lupus erythematosus-a form of skin lupus commonly...
Mount Sinai dermatologist reports Phase 3 success for rocatinlimab in moderate-to-severe eczema Dr. Kamal Kant Kohli27 May 2026 8:15 PM ISTAn international team of investigators led by Emma Guttman-Yassky, MD, PhD, Waldman Professor and System Chair of the Kimberly and Eric J. Waldman...
Folded Paramedian Forehead Flap Effective for Full-Thickness Nasal Reconstruction: Study Jacinthlyn Sylvia26 May 2026 8:15 PM ISTA new study published in the Journal of the German Society of Dermatology found that two-stage reconstruction of full-thickness nasal defects using a...
HCTZ-Linked Skin Cancer Risk Observed Primarily in White Patients: Study Jacinthlyn Sylvia26 May 2026 8:00 AM ISTA new research published in the journal of Environmental Toxicology and Pharmacology revealed that hydrochlorothiazide (HCTZ) use was associated...
Adalimumab Shown Effective and Safe in Pyoderma Gangrenosum in real world study Dr. Shravani Dali24 May 2026 11:45 PM ISTResearchers have found in a real-world study that adalimumab had no new safety concerns and was effective in treating a diverse population of patients...
Tralokinumab Effective Across Racial Groups in Atopic Dermatitis: Phase III Analysis Medha Baranwal22 May 2026 8:15 PM ISTUSA: A post-hoc analysis of phase III clinical trials suggests that tralokinumab demonstrates consistent efficacy and a favorable safety profile in...
Dupilumab Effectively Controls Severe Atopic Dermatitis: Study Finds Aashi verma21 May 2026 8:30 PM ISTA recent longitudinal cohort study found that dupilumab provides sustained, 12-month disease control for severe atopic dermatitis, with 85.2% of...
Advanced Imaging Essential for Accurate Hidradenitis Suppurativa Assessment, Suggests Study Aashi verma20 May 2026 8:15 PM ISTA recent clinical investigation has uncovered that traditional bedside assessments under-stage 58.5% of hidradenitis suppurativa (HS) cases,...
